Favorable clinical efficacy of mepolizumab on the upper and lower airways in severe eosinophilic asthma: a 48-week pilot study

Show more: Authors information and Publication history
Authors Information

1Department of Allergy and Respiratory Medicine, Sutoh Hospital, Annaka, Gunma, Japan
2Department of Radiology, Sutoh Hospital, Annaka, Gunma, Japan


Published online: 12 April 2019
Accepted: 25 March 2019
Received: 30 Januaru 2019

Table of Content: Vol. 51 (No. 5) 2019 September

European Annals of Allergy and Clinical Immunology ISSN 1764-1489 | © 2024